FDA Threatens Refusal of Imports from Canadian Fish Processor
The Food and Drug Administration may place products from Canadian seafood processor Sambro Fisheries on detention without physical examination, effectively refusing imports from the company for violations of seafood Hazard Analysis and Critical Control Point regulations, it said in a…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
warning letter. The company’s HACCP plan doesn’t list hazardous allergens for its tuna, marlin, and mahi-mahi, nor does it define a critical control point of refrigerated storage to control scombrotoxin formation. If the company doesn’t respond in 15 days from receipt of the letter, or FDA deems its response inadequate, FDA may refuse admission.